These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 385857)

  • 21. Effects of hydroquinones on intact Trypanosoma cruzi epimastigotes.
    Aldunate J; Traipe L; Spencer P; Morello A; Repetto Y
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Sep; 103(1):97-100. PubMed ID: 1360379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protein family TcTASV-C is a novel Trypanosoma cruzi virulence factor secreted in extracellular vesicles by trypomastigotes and highly expressed in bloodstream forms.
    Caeiro LD; Alba-Soto CD; Rizzi M; Solana ME; Rodriguez G; Chidichimo AM; Rodriguez ME; Sánchez DO; Levy GV; Tekiel V
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006475. PubMed ID: 29727453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The presence of rotenone-sensitive NADH dehydrogenase in the long slender bloodstream and the procyclic forms of Trypanosoma brucei brucei.
    Beattie DS; Howton MM
    Eur J Biochem; 1996 Nov; 241(3):888-94. PubMed ID: 8944779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phosphate assimilation by Trypanosoma cruzi. Partial effect of metabolic inhibitors].
    De Boiso JF; Stoppani AO
    Rev Soc Argent Biol; 1970; 46(5):124-33. PubMed ID: 4946319
    [No Abstract]   [Full Text] [Related]  

  • 26. Trypanosoma cruzi soluble antigen. Role in immunofluorescence, complement fixation and inhibition of hemagglutination tests.
    Guimarães MC; Ribeiro MT; Camargo ME
    Rev Inst Med Trop Sao Paulo; 1977; 19(3):182-90. PubMed ID: 341268
    [No Abstract]   [Full Text] [Related]  

  • 27. Metabolic requirements for the damage of Trypanosoma cruzi epimastigotes by human polymorphonuclear leukocytes.
    Cardoni RL; Docampo R; Casellas AM
    J Parasitol; 1982 Aug; 68(4):547-52. PubMed ID: 6288905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of platelets in the in vivo removal of T. cruzi from circulation.
    Umekita LF; Mota I
    Braz J Med Biol Res; 1990; 23(6-7):593-6. PubMed ID: 2101079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the toxicity of 3-allyl-beta-lapachone against Trypanosoma cruzi bloodstream forms.
    Gonçalves AM; Vasconcellos ME; Docampo R; Cruz FS; de Souza W; Leon W
    Mol Biochem Parasitol; 1980 Jun; 1(3):167-76. PubMed ID: 6777696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of isoxazolyl-naphthoquinoneimines on growth and oxygen radical production in Trypanosoma cruzi and Crithidia fasciculata.
    de Tarlovsky MN; Goijman SG; Molina Portela MP; Stoppani AO
    Experientia; 1990 May; 46(5):502-5. PubMed ID: 2189749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated cytotoxicity to Trypanosoma cruzi. II. Antibody-dependent killing of bloodstream forms by mouse eosinophils and neutrophils.
    Kipnis TL; James SL; Sher A; David JR
    Am J Trop Med Hyg; 1981 Jan; 30(1):47-53. PubMed ID: 7011071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanosoma cruzi: inhibition of parasite growth and respiration by oxazolo(thiazolo)pyridine derivatives and its relationship to redox potential and lipophilicity.
    Maya JD; Morello A; Repetto Y; Rodríguez A; Puebla P; Caballero E; Medarde M; Núñez-Vergara LJ; Squella JA; Ortiz ME; Fuentealba J; San Feliciano A
    Exp Parasitol; 2001 Sep; 99(1):1-6. PubMed ID: 11708828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the respiratory chain of Leishmania donovani promastigotes.
    Santhamma KR; Bhaduri A
    Mol Biochem Parasitol; 1995 Dec; 75(1):43-53. PubMed ID: 8720174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway.
    Garg N; Nunes MP; Tarleton RL
    J Immunol; 1997 Apr; 158(7):3293-302. PubMed ID: 9120286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxygen-derived radicals from Trypanosoma cruzi-stimulated human neutrophils.
    Docampo R; Casellas AM; Madeira ED; Cardoni RL; Moreno SN; Mason RP
    FEBS Lett; 1983 May; 155(1):25-30. PubMed ID: 6301881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of t-butyl-4-hydroxyanisole and other phenolic antioxidants on tumoral cells and Trypanosoma parasites.
    Ferreira J; Coloma L; Fones E; Letelier ME; Repetto Y; Morello A; Aldunate J
    FEBS Lett; 1988 Jul; 234(2):485-8. PubMed ID: 3292295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How Trypanosoma cruzi deals with oxidative stress: Antioxidant defence and DNA repair pathways.
    Machado-Silva A; Cerqueira PG; Grazielle-Silva V; Gadelha FR; Peloso Ede F; Teixeira SM; Machado CR
    Mutat Res Rev Mutat Res; 2016; 767():8-22. PubMed ID: 27036062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of specific antibodies in Trypanosoma cruzi infections.
    Krettli AU; Brener Z
    J Immunol; 1976 Mar; 116(3):755-60. PubMed ID: 815433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active entry of bloodstream forms of Trypanosoma cruzi into macrophages.
    Kipnis TL; Calich VL; da Silva WD
    Parasitology; 1979 Feb; 78(1):89-98. PubMed ID: 105337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Exoantigens of Trypanosoma cruzi. Epitopes reactive against immunoglobulins of patients with Chagas' disease].
    Gruppi A; Moretti ER; Basso B; Vottero-Cima E
    Medicina (B Aires); 1988; 48(2):161-6. PubMed ID: 3148093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.